General Meeting
The general meeting is Ascelia Pharma’s highest decision-making body. At the general meeting, the shareholders exercise their voting rights in key issues. To attend and vote at the general meeting, either in person or through a proxy, shareholders must be registered in the share register kept by Euroclear Sweden AB five business days prior to the meeting and also register their participation to Ascelia Pharma no later than on the date specified in the notice convening the meeting.
Documents related to general meetings are found in the table below.
Notice of Extraordinary General Meeting (EGM) 2024
The shareholders in Ascelia Pharma AB (publ) are invited to the EGM which will be held on 14 August 2024 at 14:00 CET at the premises of Setterwalls offices. For more information you can contact Julie Waras Brogren by email jwb@ascelia.com
Annual General Meeting (AGM) 2024
The AGM of Ascelia Pharma AB (publ) was held on 6 May 2024 at 14:00 CET. Shareholders requesting information regarding the AGM:
jwb@ascelia.com or by mail to: ASCELIA PHARMA AB, Hyllie Boulevard 34; SE-215 32 Malmö.
Suggestions to the AGM must reach the Board of Directors at least seven weeks prior to the meeting or in good time for the matter, if necessary, to be included in the notice to the AGM.